J. Isaacs

A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease

John D Isaacs, J. Isaacs, C. Hilkens, 2012, Annals of the rheumatic diseases.

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

C. Potter, K. Hyrich, D. Plant, 2008, Annals of the rheumatic diseases.

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

C. Wijmenga, J. Barrett, B. Lie, 2017, American journal of human genetics.

Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis

Jing Cui, Philip L. De Jager, Barbara E. Stranger, 2013, PLoS genetics.

A High-Throughput Amplicon Screen for Somatic UBA1 Variants in Cytopenic and Giant Cell Arteritis Cohorts

J. Hollywood, S. Savic, C. Cargo, 2022, Journal of Clinical Immunology.

Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39

S. Raychaudhuri, M. Weinblatt, K. Ikari, 2019, Annals of the rheumatic diseases.

High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort

A. Barton, J. Isaacs, Anthony G. Wilson, 2016, Annals of the rheumatic diseases.